TrialLeukemia2014

Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center.

D M Stephens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.